KESTRA MEDICAL TECHNOLOGIES
KMTSNASDAQTrading Snapshot
- Day Range
- $29.51 β $31.00
- 52-Week Range
- $17.34 β $30.42
- Volume (shares)
- 41,621
- Avg Volume (shares)
- β
- Shares Outstanding
- 59.6M
- Next Earnings
- 2026-12-11
Fundamentals Snapshot
- Annual Revenue
- $95M
- Last Q Revenue
- $31M
- P/E Ratio
- β
- P/S Ratio
- 16.7x
- EPS (TTM)
- $-2.67
- Dividend Yield
- β
- Dilution (1yr)
- +14.0%
KESTRA MEDICAL TECHNOLOGIES
KMTSAbout KESTRA MEDICAL TECHNOLOGIES
Kestra Medical Technologies, Ltd. operates at the intersection of wearable medical technology and digital healthcare. Its core mission is to revolutionize patient outcomes in cardiovascular disease through intelligent, intuitive, and connected monitoring and therapeutic intervention solutions. The company's flagship offering is the Cardiac Recovery System (CRS) platform, which it develops and commercializes. This unified solution seamlessly integrates cardiac monitoring, therapeutic treatment, digital health capabilities, and patient support services. A central component of the CRS is the ASSURE WCD, a wearable cardioverter defibrillator specifically engineered to protect individuals at elevated risk of sudden cardiac arrest (SCA). Beyond its hardware, the CRS platform also encompasses a suite of integrated digital solutions and services. These are designed to foster enhanced engagement and oversight between patients and healthcare providers, ultimately striving for improved patient well-being. Founded in 2014, the company is headquartered in Kirkland, Washington.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Ratings
βLatest News & Updates
News unavailable.